Breastfeeding during R-CHOP chemotherapy: please abstain!

Eur J Cancer. 2019 Sep:119:107-111. doi: 10.1016/j.ejca.2019.07.012. Epub 2019 Aug 19.

Authors

Giovanni Codacci-Pisanelli¹, Richard J Honeywell², Natalie Asselin³, Giulia Bellettini⁴, Godefridus J Peters², Elisa Giovannetti⁵, Fedro A Peccatori⁶

Affiliations

¹ Dept. Medical and Surgical Sciences and Biotechnology, University of Rome "la Sapienza", Italy. Electronic address: [email protected].
² Laboratory Medical Oncology, VU University Medical Center, CCA 1.52, Amsterdam, the Netherlands.
³ Shediac, Canada.
⁴ ASST Milan, Milan, Italy.
⁵ Laboratory Medical Oncology, VU University Medical Center, CCA 1.52, Amsterdam, the Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, Pisa, Italy.
⁶ European Institute of Oncology IRCCS, Division of Gynecologic Oncology, Milan, Italy.

PMID: 31437753
DOI: 10.1016/j.ejca.2019.07.012

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Allopurinol / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / analysis
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Feeding*
Chromatography, Liquid
Cyclophosphamide / administration & dosage
Cyclophosphamide / analysis
Cyclophosphamide / metabolism
Doxorubicin / administration & dosage
Doxorubicin / analogs & derivatives
Doxorubicin / analysis
Doxorubicin / metabolism
Female
Humans
Infant, Newborn
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Mass Spectrometry
Milk, Human / chemistry*
Prednisone / administration & dosage
Pregnancy
Pregnancy Complications, Neoplastic / diagnosis
Pregnancy Complications, Neoplastic / drug therapy*
Rituximab / administration & dosage
Vincristine / administration & dosage

Substances

Rituximab
Vincristine
Allopurinol
Doxorubicin
Cyclophosphamide
adriamycinol
Prednisone